brilliant blue g · Dutch Ophthalmic · NDA 209569
Tissueblue
Earliest generic entry, as listed
20 Dec 2026
Blocked by exclusivity: ODE-282.
Listed patents · 0 unexpired
No unexpired patents listed.
Exclusivities · 1 unexpired
| ODE-282 | orphan drug (7 years) | 20 Dec 2026 |
Paragraph IV certifications · 0
No Paragraph IV certification listed by FDA for this drug.
The list shows that a generic applicant certified to FDA that a listed patent is invalid or not infringed. It does not show litigation, settlements or launch timing.
Event history
- Exclusivity expires within 90 days ODE-282 · 209569-001Exclusivity expires 20 Dec 2026Detected 24 Oct 2026
- Enters 12-month window basis: exclusivity · 209569-001Listed date 20 Dec 2026Detected 24 Oct 2026
Products covered · 1
| NDA · product | Form | Strength | Listed expiry |
|---|---|---|---|
| 209569 · 001 · RLD | solution, ophthalmic | 0.025% | 20 Dec 2026 |